Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature 452, 38-39 (6 March 2008) | doi:10.1038/452038a; Published online 5 March 2008
Open Innovation Challenges
-
Efficient Chromosome Doubling: Plant Cell Division
The Seeker is looking for an efficient chromosome doubling method in plants and in particular, metho...
-
Protect Enzyme from In Planta Degradation
A proposal for stable expression of an enzyme in corn seed is desired.
nature jobs
Faculty Position in Biochemistry
- University of Tuebingen
- Tuebingen 72076 Germany
Scientist, Recombinant Protein Expression
- Novo Nordisk Foundation Center for Protein Research, University of Copenhagen
- Copenhagen 2200 Denmark
Neuroscience: A complex in psychosis
Solomon H. Snyder1
Abstract
The molecular basis of psychoses such as schizophrenia remains largely mysterious. The interaction between two of the brain receptors involved adds to evidence that will help in the search for explanations.
This is a story that involves three types of receptor in the brain that influence human perception and behaviour (those for the neurotransmitters dopamine, serotonin and glutamate), and the drugs that block or enhance their activity. Such drugs are used by researchers to investigate the causes of psychotic disorders such as schizophrenia, and by clinicians to treat patients.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Hallucinogens and PsychosisNature News and Views (11 Nov 1967)
Research HighlightsNature Medicine News and Views (01 Mar 2008)
RESEARCH
Identification of a serotonin/glutamate receptor complex implicated in psychosisNature Letters to Editor (06 Mar 2008)
Chronic Phenethylamine Hallucinogen Treatment Alters Behavioral Sensitivity to a Metabotropic Glutamate 2/3 Receptor AgonistNeuropsychopharmacology Original Article
See all 3 matches for Research
